Le Lézard
Subjects: Product/Service, Funding

Baxter Funds University Scholarships to Support Students From Underrepresented Groups and Communities in the UK and Ireland


Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today three new collaborations to support financially in-need students from multicultural backgrounds pursuing degrees at UCL, Dublin City University and Trinity College Dublin. Baxter's funding will support 10 students in total over the 2023/2024 and 2024/2025 academic years.

"Through our Activating Change Today (ACT) initiative, Baxter has proudly created several programs that support students in the U.S. who are pursuing health and science degrees. The funding announced today is ACT's first investment benefiting students internationally," said Angela Lee, Baxter's chief diversity officer. "In partnership with the Baxter MultiCultural Network business resource group?which promotes inclusion and belonging by embracing diversity among different dimensions of race, ethnicity and culture?we're delighted to work with three higher-educational institutions in the UK and Ireland to help address barriers to education that can exist at the intersection of ethnicity and affordability."

Each of the institutions are applying Baxter's contributions to best meet the needs of their respective student bodies. This includes:

About Baxter

Every day, millions of patients, caregivers and healthcare providers rely on Baxter's leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For more than 90 years, we've been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on X/Twitter, LinkedIn and Facebook.

Baxter is a registered trademark of Baxter International Inc. or its subsidiaries.



News published on and distributed by: